189 related articles for article (PubMed ID: 33091817)
21. Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study.
Chilimuri S; Sun H; Alemam A; Kang KS; Lao P; Mantri N; Schiller L; Sharabun M; Shehi E; Tejada J; Yugay A; Nayudu SK
J Clin Pharm Ther; 2021 Apr; 46(2):440-446. PubMed ID: 33098139
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 therapy and prevention.
Claude-Rosny E
Discoveries (Craiova); 2020 Sep; 8(3):e113. PubMed ID: 33094148
[TBL] [Abstract][Full Text] [Related]
23. QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment.
Grewal S; Jankelson L; van den Broek MPH; Cour M; Bachmann G; Kostis JB; Misra K
Front Cardiovasc Med; 2020; 7():152. PubMed ID: 33102533
[TBL] [Abstract][Full Text] [Related]
24. Are children with SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients.
Al-Ghafry M; Aygun B; Appiah-Kubi A; Vlachos A; Ostovar G; Capone C; Sweberg T; Palumbo N; Goenka P; Wolfe LW; Lipton JM; Acharya SS
Pediatr Blood Cancer; 2020 Dec; 67(12):e28737. PubMed ID: 33098753
[TBL] [Abstract][Full Text] [Related]
25. Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada.
Hoffmann C; Wolf E
Infection; 2021 Feb; 49(1):111-116. PubMed ID: 33098532
[TBL] [Abstract][Full Text] [Related]
26. Transmission of SARS-CoV-2 in the Karaoke Room: An Outbreak of COVID-19 in Guangzhou, China, 2020.
Gu Y; Lu J; Su W; Liu Y; Xie C; Yuan J
J Epidemiol Glob Health; 2021 Mar; 11(1):6-9. PubMed ID: 33095983
[No Abstract] [Full Text] [Related]
27. Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
Bansal P; Goyal A; Cusick A; Lahan S; Dhaliwal HS; Bhyan P; Bhattad PB; Aslam F; Ranka S; Dalia T; Chhabra L; Sanghavi D; Sonani B; Davis JM
Ann Med; 2021 Dec; 53(1):117-134. PubMed ID: 33095083
[TBL] [Abstract][Full Text] [Related]
28. Potential therapeutic use of corticosteroids as SARS CoV-2 main protease inhibitors: a computational study.
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2022 Mar; 40(5):2053-2066. PubMed ID: 33094701
[TBL] [Abstract][Full Text] [Related]
29. Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease.
Zhou Z; Price CC
Expert Opin Investig Drugs; 2020 Dec; 29(12):1407-1412. PubMed ID: 33094669
[TBL] [Abstract][Full Text] [Related]
30. Zinc and COVID-19: Basis of Current Clinical Trials.
Pal A; Squitti R; Picozza M; Pawar A; Rongioletti M; Dutta AK; Sahoo S; Goswami K; Sharma P; Prasad R
Biol Trace Elem Res; 2021 Aug; 199(8):2882-2892. PubMed ID: 33094446
[TBL] [Abstract][Full Text] [Related]
31. ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial.
Davies A; Barrans S; Burton C; Mercer K; Caddy J; Chinnery F; Day L; Fernando D; Ardeshna K; Collins G; Radford J; Rule S; McMillan A; Johnson P; Griffiths G
F1000Res; 2020; 9():941. PubMed ID: 33093947
[No Abstract] [Full Text] [Related]
32. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
Allenbach Y; Benveniste O; Stenzel W; Boyer O
Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Epidemiologic Analysis of COVID-19 Children Cases in Colombia PEDIACOVID.
Bolaños-Almeida CE; Espitia Segura OM
Pediatr Infect Dis J; 2021 Jan; 40(1):e7-e11. PubMed ID: 33093428
[TBL] [Abstract][Full Text] [Related]
34. Guillain-Barré Syndrome in a Child With COVID-19 Infection.
Curtis M; Bhumbra S; Felker MV; Jordan BL; Kim J; Weber M; Friedman ML
Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33093141
[TBL] [Abstract][Full Text] [Related]
35. Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer.
Pyrgidis N; Vakalopoulos I; Sountoulides P
Hormones (Athens); 2021 Mar; 20(1):73-84. PubMed ID: 33140306
[TBL] [Abstract][Full Text] [Related]
36. Amoxicillin-clavulanic acid-induced type II Kounis syndrome during general anaesthesia complicated with hypoxic-ischaemic encephalopathy.
Peláez-Pérez JM; Sánchez Casado M; Álvarez-Twose I; Kounis NG
Rev Esp Anestesiol Reanim (Engl Ed); 2021 Mar; 68(3):161-164. PubMed ID: 33172656
[TBL] [Abstract][Full Text] [Related]
37. Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study.
Dhibar DP; Arora N; Kakkar A; Singla N; Mohindra R; Suri V; Bhalla A; Sharma N; Singh MP; Prakash A; Pvm L; Medhi B
Int J Antimicrob Agents; 2020 Dec; 56(6):106224. PubMed ID: 33166694
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study.
Derwand R; Scholz M; Zelenko V
Int J Antimicrob Agents; 2020 Dec; 56(6):106214. PubMed ID: 33122096
[TBL] [Abstract][Full Text] [Related]
39. Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.
Hetland ML; Haavardsholm EA; Rudin A; Nordström D; Nurmohamed M; Gudbjornsson B; Lampa J; Hørslev-Petersen K; Uhlig T; Grondal G; Østergaard M; Heiberg MS; Twisk J; Lend K; Krabbe S; Hyldstrup LH; Lindqvist J; Hultgård Ekwall AK; Grøn KL; Kapetanovic M; Faustini F; Tuompo R; Lorenzen T; Cagnotto G; Baecklund E; Hendricks O; Vedder D; Sokka-Isler T; Husmark T; Ljoså MA; Brodin E; Ellingsen T; Söderbergh A; Rizk M; Olsson ÅR; Larsson P; Uhrenholt L; Just SA; Stevens DJ; Laurberg TB; Bakland G; Olsen IC; van Vollenhoven R;
BMJ; 2020 Dec; 371():m4328. PubMed ID: 33268527
[TBL] [Abstract][Full Text] [Related]
40. A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).
Chen CP; Lin YC; Chen TC; Tseng TY; Wong HL; Kuo CY; Lin WP; Huang SR; Wang WY; Liao JH; Liao CS; Hung YP; Lin TH; Chang TY; Hsiao CF; Huang YW; Chung WS; Cheng CY; Cheng SH;
PLoS One; 2020; 15(12):e0242763. PubMed ID: 33264337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
